Synonyms: WX-081
Compound class:
Synthetic organic
Comment: Sudapyridine (WX-081) is the lead from a novel diarylpyridine series with antimycobacterial activity and an analogue of bedaquiline [1,3]. Sudapyridine has advanced to clinical evaluation for the treatment of tuberculosis.
|
|
No information available. |
Summary of Clinical Use |
Sudapyridine has completed a Phase 2 clinical trial (NCT04608955) assessing efficacy in patients with drug-susceptible and drug-resistant tuberculosis and has progressed to Phase 3 evaluation [2]. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04608955 | Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 | Phase 2 Interventional | Shanghai Jiatan Pharmatech Co., Ltd |